DMII

MKT CAP:$525M

Drugs Made In America Acquisition II Corp. Ordinary Shares

Market Cap

$525M

Financial Services·Shell Companies·🇺🇸 United States·NASDAQ

Financials·Shell Companies·🇺🇸·NASDAQ

Stock Price

$10.01+$0.11 (+1.11%)

Apr 21, 2026

Company Details

Drugs Made In America Acquisition II Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with ...

CEO

Roger Bendelac

IPO Date

Dec 4, 2025

Website

dmaacorp.com

Key Metrics TTM

Revenue

$0

— YoY

Net Income

-$185.2K

EPS (Diluted)

-$0.02

Free Cash Flow

-$690.7K

Revenue / Share

$0.00

Gross Margin

—

Operating Margin

—

Net Margin

—

FCF Margin

—

P/S

—

P/E

—

Earnings Reports

Q3 2025

Nov 18, 2025

$0EPS -$0.02

Q2 2025

Jun 30, 2025

$0EPS $0.00

Q1 2025

Mar 31, 2025

$0EPS -$0.00

FY 2024

Dec 30, 2024

$0EPS -$0.00

Q3 2024

Sep 29, 2024

$0EPS $0.00

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q3 24	$0	$0	-$41.7K
Q1 25	$0	$0	-$59.3K
Q2 25	$0	$0	-$38.1K
Q3 25	$0	$0	-$155.5K

Operating Cash Flow

Quarter	Operating CF	Free CF
Q3 25	-$690.7K	-$690.7K

Capital Expenditures

Quarter	CapEx
Q3 25	$4

CapEx

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q3 25	$0	—

OpEx Breakdown

Quarter	G&A	SG&A
Q3 24	—	$41.7K
Q1 25	$59.3K	—
Q2 25	$38.1K	—
Q3 25	$155.5K	—

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 25	$7.0K	$0	$7.0K
Q2 25	$4.4K	$0	$4.4K
Q3 25	$315.1K	$0	$315.1K

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q3 24	64M	—	—
Q1 25	64M	0.0%	—
Q2 25	33M	-47.9%	—
Q3 25	3M	-91.8%	—

Shares Outstanding